Author:
Camci Celalettin,Sevinc Alper,Aslan Yilmaz,Kalender Mehmet Emin,Buyukberber Suleyman
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference23 articles.
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66
2. Young RC, Decker DG, Wharton JT, Piver MS, Sindelar WF, Edwards BK, Smith JP (1983) Staging laparotomy in early ovarian cancer. JAMA 250:3072–3076
3. Samaritani R, Corrado G, Vizza E, Sbiroli C (2007) Cyclophosphamide “metronomic”chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer. BMC Cancer, doi: 10.1186/1471-2407-7-65
4. Doyle C, Crump M, Pintilie M, Oza AM (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266–1274
5. Latorre A, De Lena M, Catino A, Crucitta E, Sambiasi D, Guida M, Misino A, Lorusso V (2002) Epithelial ovarian cancer: second andthird line chemotherapy. Int J Oncol 21:179–186
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献